Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by longondmxon Oct 08, 2015 10:17am

93 Views

Post# 24174956

RE:RE:RE:RE:RE:RE:technically speaking...

If it was a real great technology, one that will really improve the productivity and profitability of a company, takers will jump on board.

Or they will just "take" it...as was alleged (but not proven).

mario99 - (10/8/2015 10:13:56 AM)
RE:RE:RE:RE:RE:technically speaking...

How can you say it is "great technology" when there are no takers.

If it was a real great technology, one that will really improve the productivity and profitability of a company, takers will jump on board.

Right now, Virusmax is dead.

I suspect Kinlytic and Lumisort are near death's bed, but MBX has to hang on to something, otherwise the price will tumble to 20 cents.

Bullboard Posts

Canadian artificial intelligence ETFs